Sri Endang Pujiastuti
Unknown Affiliation

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

THE CORRELATION BETWEEN PARITY AND BABY WEIGHT TO THE INCIDENCE OF POSTPARTUM HEMORRHAGE Adenia Dwi Ristanti; Dessy Lutfiasari; Galuh Pradian; Sri Endang Pujiastuti
Proceedings of the International Conference on Applied Science and Health No. 2 (2017)
Publisher : Yayasan Aliansi Cendekiawan Indonesia Thailand (Indonesian Scholars' Alliance)

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: The most dominating factors of maternal deaths is postpartum hemorrhage, which predominantly caused by parity 4.20%, baby weight 3.55%, retention 1.94%, uterine atony 1.29%, and age of mother 1.94%. Aims: The purpose of this study was to determine the correlation between parity and baby weight on the incidence of postpartum hemorrhage at Gambiran hospital Kediri in 2015. Methods:This is a quantitative research using Rank Spearman and multiple logistic regression. statistics test. The population of this study is all women who giving birth at Gambiran hospital Kediri from January- March 2015, with total 309 respondents. By using simple random sampling technique, 175 respondents was selected for this study. Results: Results showed most of respondents (70.9%) gave birth normally and more than a half (51.4%) have experienced with postpartum hemorrhage. Its highly significant that lower baby weight and parity have correlated with the incidence of postpartum hemorrhage,while the most influence of postpartum hemorrhage was lower baby weight (4 times more risk) and 3.3 more risk for parity. Conclusion: The parity and lower baby weight have positive correlation and influences with postpartum hemorrhage. Based on the results of the study the health workers expected to improve the quality of service on antenatal to decrease the number of postpartum hemorrhage. 
THE EFFECT OF IRON POLYMALTOSE COMPLEX TABLET ADMINISTRATION TO INCREASE HEMOGLOBIN LEVEL AMONG PREGNANT WOMEN WITH ANEMIA Cahyaning Puji Astuti; Melyana Nurul Widyawati; Sri Endang Pujiastuti
Proceedings of the International Conference on Applied Science and Health No. 2 (2017)
Publisher : Yayasan Aliansi Cendekiawan Indonesia Thailand (Indonesian Scholars' Alliance)

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Background: Anemia is a major cause of bleeding due to iron deficiency. Iron tablets which contain 60 mg of Ferrous Sulphate and 0.25 mg of folic acid did not show good results in changing the body’s iron level and there are many perceived side effects. However, there is now exists an oral iron tablets in the form of available salt compounds of ferrous fumarate, ferrous sulphate, and ferrous gluconate. These tablets contain iron hydroxide polymaltose complex (III) or better known as IPC (Iron Polymaltose Complex) and have minimal side effects. Aims: To understand the effect of IPC tablets in increasing the hemoglobin level in pregnant women with anemia. Methods: This study used quantitative study with pre-experimental design, or experiments that have not been applied in real terms. This study used non-probability sampling technique and purposive sampling for the selected sample. The sample were 35 people based on the inclusion criteria. The design used was one group pre-test – post-test approach without the control group. The subjects undertook the anemia examination on the first day (pre-test) and afterwards were administered 100mg IPC tablets daily for the next 30 days. In the end of the intervention, the subjects were re-examined and the results were compared (post-test). Results: The study showed that there is a significant increase of hemoglobin level in pregnant women with anemia with p value = 0.023 (p<0.05) after the intervention in the form of IPC tablet administration was conducted for 30 days. Conclusion: The intervention performed in administration of IPC tablets for pregnant women with anemia showed a significant increase of hemoglobin level before and after the provision of IPC tablets.